BioReact Secures Investment from University of Tulsa and Hurricane Ventures for AI-Powered Bioprocess Optimization
Bioreactors do not care about your feelings. They care about temperature, pH, dissolved oxygen, feed rates, timing. Miss 1 variable and your yield ghosts you. That quiet frustration inside every...
Bioreactors do not care about your feelings. They care about temperature, pH, dissolved oxygen, feed rates, timing. Miss 1 variable and your yield ghosts you. That quiet frustration inside every biotech lab is where BioReact decided to set up shop.
BioReact just locked in a $1.07M oversubscribed pre-seed round led by New Stack Ventures, with PhyCap, Hurricane Ventures, Plug and Play, Soren White, and Service Provider Capital stepping in. Then in February 2026, UTulsa’s Hurricane Ventures doubled down with a separate investment announcement, amount undisclosed. When smart capital leans twice, it is not by accident.
Mitchell J. Castetter, Founder and CEO, knows the pain from the sales floor. More than a decade at Beckman Coulter and Cytena, over $10M in life science equipment moved. You do not sell that much hardware without hearing what actually breaks in the lab. What breaks is not ambition. It is data.
Joanna Lipinski, Ph.D., Co-Founder and CTO, brings 20+ years building advanced software and data platforms across high-tech and biotech. Discovery informatics, bioinformatics, data science. The kind of résumé that does not blink at messy datasets. Together they built BioReact as the intelligence layer for bioprocessing. Not another dashboard. A system that ingests data from bioreactors, spreadsheets, offline assays, aligns time series automatically, and turns 4–5 hours of manual wrangling into seconds.
Opti-ML is their proprietary engine, optimizing temperature, pH, nutrient concentrations, media composition. Yield, titer, robustness. Integrations with Sartorius, Infors, and Eppendorf. Tools like DOE, PCA, factor importance. And scientists do not need to code. That matters, because the future of biotech will not be won by who hires the most data scientists. It will be won by who empowers the bench.
Nate Carey, Cofounder and Director of Business Development, bridges science and strategy, helping translate platform power into partnerships. The company reports 600+ monthly active users and over 20M+ data points uploaded. Self-reported, yes, but directionally clear. Labs are logging in.
They sharpened their blade through gBETA Life Sciences and Techstars Miami Powered by J.P. Morgan, where the standard Techstars investment applies. Accelerators teach speed. Venture teaches discipline. Customers teach truth.
Chris Wright, Ph.D., Assistant Vice President for Innovation and Entrepreneurship at The University of Tulsa, and Connor Sitton, Director of Hurricane Ventures, are betting that bioprocess data deserves its own operating system. Ariella Frank and Nick Moran at New Stack Ventures saw it early. When multiple ecosystems converge around a data infrastructure play in biotech, you pay attention.
Because this is bigger than 1 round. Industrial biotech, biopharma, synthetic biology, they all run on bioreactors. And bioreactors run on data. The lab that learns fastest wins. The company that structures that learning becomes indispensable.